BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28406452)

  • 1. Suppression of Hepatic Epithelial-to-Mesenchymal Transition by Melittin via Blocking of TGFβ/Smad and MAPK-JNK Signaling Pathways.
    Park JH; Park B; Park KK
    Toxins (Basel); 2017 Apr; 9(4):. PubMed ID: 28406452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apamin inhibits hepatic fibrosis through suppression of transforming growth factor β1-induced hepatocyte epithelial-mesenchymal transition.
    Lee WR; Kim KH; An HJ; Kim JY; Lee SJ; Han SM; Pak SC; Park KK
    Biochem Biophys Res Commun; 2014 Jul; 450(1):195-201. PubMed ID: 24878534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total flavone of
    Yang BL; Zhu P; Li YR; Xu MM; Wang H; Qiao LC; Xu HX; Chen HJ
    World J Gastroenterol; 2018 Aug; 24(30):3414-3425. PubMed ID: 30122880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperine inhibits AML-12 hepatocyte EMT and LX-2 HSC activation and alleviates mouse liver fibrosis provoked by CCl
    Shu G; Yusuf A; Dai C; Sun H; Deng X
    Food Funct; 2021 Nov; 12(22):11686-11703. PubMed ID: 34730139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.
    Choi YJ; Kim DH; Kim SJ; Kim J; Jeong SI; Chung CH; Yu KY; Kim SY
    Life Sci; 2014 Jul; 108(2):94-103. PubMed ID: 24880074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamine inhibits CCl4 induced liver fibrosis in mice and TGF-β1 mediated epithelial-mesenchymal transition in mouse hepatocytes.
    Shrestha N; Chand L; Han MK; Lee SO; Kim CY; Jeong YJ
    Food Chem Toxicol; 2016 Jul; 93():129-37. PubMed ID: 27137983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schizandrin inhibits fibrosis and epithelial-mesenchymal transition in transforming growth factor-β1-stimulated AML12 cells.
    Park JH; Yoon J
    Int Immunopharmacol; 2015 Apr; 25(2):276-84. PubMed ID: 25701504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elk-3 Contributes to the Progression of Liver Fibrosis by Regulating the Epithelial-Mesenchymal Transition.
    Li TZ; Kim SM; Hur W; Choi JE; Kim JH; Hong SW; Lee EB; Lee JH; Yoon SK
    Gut Liver; 2017 Jan; 11(1):102-111. PubMed ID: 27538444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin pretreatment inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition via the downregulation of toll-like receptor 4 and nuclear factor-κB in human biliary epithelial cells.
    Kim Y; Lee EJ; Jang HK; Kim CH; Kim DG; Han JH; Park SM
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1220-8. PubMed ID: 26574150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveolin-1 Scaffolding Domain Peptides Alleviate Liver Fibrosis by Inhibiting TGF-β1/Smad Signaling in Mice.
    Lu J; Zhang J; Wang Y; Sun Q
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emodin suppresses activation of hepatic stellate cells through p38 mitogen-activated protein kinase and Smad signaling pathways in vitro.
    Wang X; Niu C; Zhang X; Dong M
    Phytother Res; 2018 Dec; 32(12):2436-2446. PubMed ID: 30117601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin inhibits cobalt chloride-induced epithelial-to-mesenchymal transition associated with interference with TGF-β/Smad signaling in hepatocytes.
    Kong D; Zhang F; Shao J; Wu L; Zhang X; Chen L; Lu Y; Zheng S
    Lab Invest; 2015 Nov; 95(11):1234-45. PubMed ID: 26302188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of early liver fibrosis by herbal compound "Diwu Yanggan" through modulating the balance between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition.
    Shen X; Cheng S; Peng Y; Song H; Li H
    BMC Complement Altern Med; 2014 Oct; 14():418. PubMed ID: 25345787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic effect.
    Xu L; Zheng N; He Q; Li R; Zhang K; Liang T
    Phytomedicine; 2013 Oct; 20(13):1172-9. PubMed ID: 23856441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melittin inhibits TGF-β-induced pro-fibrotic gene expression through the suppression of the TGFβRII-Smad, ERK1/2 and JNK-mediated signaling pathway.
    Park SH; Cho HJ; Jeong YJ; Shin JM; Kang JH; Park KK; Choe JY; Park YY; Bae YS; Han SM; Moon SK; Kim WJ; Choi YH; Chang YC
    Am J Chin Med; 2014; 42(5):1139-52. PubMed ID: 25178280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquiritigenin inhibits hepatic fibrogenesis and TGF-β1/Smad with Hippo/YAP signal.
    Lee EH; Park KI; Kim KY; Lee JH; Jang EJ; Ku SK; Kim SC; Suk HY; Park JY; Baek SY; Kim YW
    Phytomedicine; 2019 Sep; 62():152780. PubMed ID: 31121384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-β1/Smad signaling pathways.
    Li T; Zhao N; Lu J; Zhu Q; Liu X; Hao F; Jiao X
    Bioengineered; 2019 Dec; 10(1):282-291. PubMed ID: 31311401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evodiamine might inhibit TGF-beta1-induced epithelial-mesenchymal transition in NRK52E cells via Smad and PPAR-gamma pathway.
    Wei J; Li Z; Yuan F
    Cell Biol Int; 2014 Jul; 38(7):875-80. PubMed ID: 24604887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
    Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
    J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
    Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH
    Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.